VEGFA and neoplasm: The above findings provide new directions for the treatment of MPE, and therapeutic approaches targeting increased tumor angiogenesis and permeability, such as a recombinant human vascular endothelial inhibitors and VEGF monoclonal antibodies, have improved efficacy in the treatment of MPE.